摘要
应用单向免疫扩散法检测98例健康成人和294例各种不同性质疾病患者血清C1-INH含量。结果表明,慢性乙型肝炎和肝硬化患者共41例血清C1-INH含量显著降低,其余患者都显著增高,恶性肿瘤组显著高于非恶性肿瘤组,未转移的恶性肿瘤患者在手术以后显著低于手术以前,而恶性肿瘤广泛转移和复发以后又重新增高。提示:C1-INH含量测定可以作为临床疾病的诊断、治疗和预后的一个指标。
The serum C1-INH level in 98 healthy adults and 294 cases with different disease was studied by SIRD. The results showed that serum C1-INH reduced in 41 cases with hepatic cirrhosis and chronic hepatitis B, but obviously increa-ded in other cases. Malignant tumor group was obvious higher than no-malignant tumor group. While after operation malignant tumor group C1-INH was obvious reduced, but when extensive transtatic or relapse CJ-INH was increasing again. It's suggested that assay for estimating diagnosis and prognosis of malignant tumor.
出处
《免疫学杂志》
CAS
CSCD
北大核心
1992年第3期188-191,共4页
Immunological Journal
关键词
酯酶抑制剂
免疫扩散法
C_1^--esterase inhibitor (C1-INH) , SIRD
